Glucocorticoid (GC) hormones can bind two structurally and functionally related steroid receptors: the GC Receptor (GR or Nr3c1) and the mineralocorticoid receptor (MR or Nr3c2), which recognize the same DNA response elements and act as ligand-dependent transcription factors. While the crucial role of GR for skin homeostasis has been widely characterized, the exact role of MR in this tissue deserves further study. We assessed NR3C2 expression in developing and adult WT mouse skin and found a transient peak at embryonic day (E)16.5, which along with low levels of HSD11B2, the enzyme inactivating GCs, supports a role for GC-MR complexes in epidermal maturation. Consistent with this observation, MR -/-embryonic skin showed alterations in early epidermal differentiation that resolved postnatally. The lack of a more severe skin phenotype of MR -/-mice suggests functional compensation by GR in this tissue in the perinatal period.
Background
The importance of hormonal regulation in skin is evidenced by numerous endocrine abnormalities with cutaneous manifestations, including disorders of the epidermal barrier and hair (1, s1) . Hormone action is mediated by nuclear receptor superfamily members, ligandactivated transcription factors that integrate multiple cellular processes, including the glucocorticoid (GC) receptor (GR or Nr3c1) and the mineralocorticoid receptor (MR or Nr3c2) (2). Both proteins are structurally and functionally related, and upon GC binding recognize the same hormone responsive elements to transcriptionally regulate target genes (3) (4) (5) . GC access to GR and MR is modulated by two enzymes, 11-hydroxy steroid dehydrogenases type I and II (HSD11B1/HSD11B2), which mediate interconversion between inactive and active GCs. Human and mouse skin can synthesize GCs and key enzymes of steroid synthesis, acting as a functional hypothalamo-pituitary-adrenal axis to secure epidermal homeostasis (6, s2, s3) . While our previous work demonstrated that GR is required for epidermal development and homeostasis (7, 8, s4) , much less is known regarding MR in this tissue (9). Remarkably, transgenic mice with keratinocyte-specific overexpression of either MR or GR (s5, s6) showed strong phenotypical similarities at birth including atrophic skin, reduced hair follicle number, and impaired epidermal maturation.
Questions addressed
We have analyzed: i) MR expression during mouse skin development; ii) the consequences of MR inactivation in developing mouse skin; and iii) the relative expression of HSD11B1/HSD11B2 during this process.
Experimental design
Animal Experimentation MR -/ -mice were generated using generalized CRE-mediated recombination by intercrossing K5-cre mice (s7) and MR loxP / loxP mice (s8).
Sample processing
Skin samples were collected from at least three individuals of each genotype and age and analyzed as reported (8). Mean value ± SD was calculated and statistical significance assessed using the Student's t-test (8).
Results
We analyzed the relative expression of Nr3c2 by RT-QPCR in WT embryonic (E)18.5 and adult mouse skin in the telogen (8-wk old) and anagen (5-wk old) phases of the hair cycle. Nr3c2 levels were 17-fold higher in telogen relative to anagen skin, suggesting a role for MR in the resting phase of the hair cycle; however, Nr3c2 was most abundant in E18.5 skin, 5-fold higher than in telogen adult skin (Fig. 1A) . Assessment of Nr3c2 during skin development revealed a peak in expression at E16.5 which decreased thereafter (E18.5 and postnatal day 0 (P0); Fig.  1B ). These findings were paralleled by changes in MR protein expression in developing and adult skin (Fig. 1C) . Nr3c1 levels also peaked in E16.5 skin but unlike Nr3c2 did not decrease at later timepoints (Fig. S1 ). Krt77 and Sprr2d are controls known to be expressed differentially during epidermal development (Fig. S1) .
To evaluate the consequences of MR loss-of-function in developing skin, we generated MR -/-mice ( Fig. 1D ) using generalized CRE-mediated recombination in MR loxP / loxP mice (Supp. Information; s7, s8). MR -/-mice died perinatally around P10 similar to MR null/null mice (s9), presumably due to renal loss of sodium and water (not shown). Epidermal permeability assays in MR +/-and MR -/-E17.5 embryos showed no major changes in the pattern of barrier formation among genotypes (Fig. 1E) . However, analysis of Hematoxylin/Eosin stained skin sections showed statistically significant increases of epidermal thickness in MR -/-relative to MR +/-embryos ( Fig. 1E, F ). Altered differentiation, with a more restricted expression of keratin (K)5 and abnormal expression patterns of K10 and loricrin (LOR) were also detected in MR -/-embryos and quantitated as minor but statistically significant changes of percent positive layers ( Fig. 1E , G). These alterations resolved spontaneously with age as MR -/-skin had a similar appearance as MR +/-or WT littermates at P0 and P4 ( Fig. 2 and data not shown). We assessed stratum corneum lipids by Nile red staining and quantitated epidermal thickness and loricrin staining in postnatal skin samples but found no changes among genotypes ( Fig. 2A and S2 ). MR -/-epidermal proliferation was unchanged at P0 but statistically significant increases were detected at P4 (Fig. 2B ), relative to controls; however, we cannot exclude the possibility that the MR -/-postnatal renal defects indirectly affect proliferation in this tissue.
To understand whether the transient role of MR in epidermal development is due to alterations in GC availability, we assessed Hsd11b1 and Hsd11b2 in skin at distinct stages and observed pronounced peaks in expression for both genes at E18.5 (Fig. 2C) . In adult skin, the expression of Hsd11b1 decreased 2-fold and that of Hsd11b2 more than 30-fold relative to E18.5. Immunostaining confirmed the restricted expression of HSD11B2 to the upper epidermal layers with statistically significant increases at P0 (Fig. 2D and S3A) . Importantly, HSD11B2 epidermal expression was similar in MR +/+ vs MR -/-mice but decreased significantly in GR -/-skin ( Fig. 2E and S3B ). The -subunit of the amiloride-sensitive epithelial Na channel (ENaC/Scnn1a), necessary for epidermal homeostasis, is a transcriptional target of both MR and GR (s10). We assessed whether the absence of MR affected ENaC but found no differences in P0 skin (Fig.  S4 ), similar to that reported in colon and kidney of MR -/-newborn mice (s11). The fact that Nr3c1 levels are unchanged in MR -/-skin suggests that GR expression is not negatively affected by loss of MR (Fig. S4 ).
Conclusions
Our findings indicate that MR plays a role in regulating epidermal differentiation at late embryonic stages. The transient expression peak of MR at E16.5, coinciding with low levels of HSD11B2, argues for a role of GC-MR complexes in epidermal maturation. The fact that HSD11B2 was virtually absent in GR -/ -skin but normally expressed in MR -/-skin, together with its reported induction by dexamethasone in human keratinocytes (s12), suggests this enzyme is regulated by GR but not MR, and may represent a mechanism to modulate GC-dependent actions locally. The hypothalamo-pituitary-adrenal axis becomes active around E15.5 ensuring proper control of circulating GC and aldosterone levels, which are normally high perinatally (s13). MR and GR expression peaks shortly afterwards, at E16.5. MR expression decreases at later developmental timepoints while that for GR remains constant. This observation together with our phenotypic data supports the hypothesis that MR plays a transient role in skin development. While GR -/-late embryos featured defective epidermal differentiation with virtually absent stratum corneum and impaired barrier function (s4), the skin phenotype of MR -/-embryos was relatively milder suggesting functional compensation by GR in the perinatal period. A. RT-QPCR data showing relative Nr3c2 mRNA levels in WT developing (embryonic E18.5) and telogen and anagen adult mouse skin. Asterisks indicate statistically significant differences relative to E18.5. (n= 3 per age; * p-value <0.05; *** p-value <0.001). B. Relative Nr3c2 mRNA levels in embryonic (E15.5-E18.5) and newborn (P0) mouse skin. Asterisks indicate statistically significant differences relative to E15.5 (n= 4 per age; *** p-value <0.001). C. Western blot showing MR protein in developing (E16.5, E18.5, P0) and adult mouse skin (8-wk old). Kidney whole cell extracts from MR -/-P0 or WT adult (K) demonstrate the specificity of the MR antibody. Actin is used as a loading control. D. Nr3c2 transcript levels were assessed in MR +/+ , MR +/-, and MR -/-P0 skin. Asterisks indicate statistically significant differences relative to MR +/+ (n= at least 3 per genotype; ** pvalue <0.01; *** p-value <0.001). E. Left panels: Epidermal permeability was assessed in E17.5 MR +/-and MR -/-mice (n=22) by toluidine blue staining. Blue denotes immature epidermis and white indicates mature epidermis. Right panels: Histological analysis. H&E indicates hematoxylin/eosin staining. Brackets illustrate differences in epidermal thickness, which were quantitated in panel F; asterisks indicate altered epidermal differentiation. Bar: 100 m. F-G. Morphometric quantitation of epidermal thickness (F) and immunohistochemistry (G). Percentage of K5-, K10-, and loricrin (LOR)-positive layers is shown in G. Asterisks indicate statistically significant differences relative to MR +/-(n= 7 per genotype; * p<0.05, ** p<0.01, *** p<0.001).
Fig. 2. Skin architecture of postnatal MR
-/-mice, and HSD11B2 expression during skin development. A. Hematoxylin/eosin (H&E) staining, immunolocalization of loricrin (LOR), and lipid distribution (Nile red staining) were examined in skin sections collected from MR +/-and MR -/-mice at P0 and P4. B. Epidermal proliferation was assessed in MR +/-and MR -/-P0 skin by in vivo BrdU incorporation. Statistically significant changes among genotypes were detected only at P4 (n= 6 per genotype; ** p-value <0.01). C. Hsd11b1 and Hsd11b2 mRNA levels were assessed in developing (E16.5, E18.5, P0) and adult mouse skin by RT-QPCR. Asterisks indicate statistically significant differences relative to E16.5 (n=3 per age; * p-value < 0.05; ** p-value < 0.01). D-E. Immunohistochemistry for HSD11B2 in skin sections from E16.5, E18.5 and P0 WT mice (n=12), as well as in P0 MR +/+ , MR -/-and GR -/-skin (n=12). Bars: 100 m. 
